All the surprising clues your nose can reveal about your health
But scientists now say the color of the mucus coming from your nose could reveal hidden warning signs about your health.
Human bodies make about 100 milliliters of snot every day — equivalent to 6.5tbsp — which is mostly washed down the throat into the stomach, although some also exits through the nose.
Doctors have spent years studying the mucus - commonly called snot - and have divided it into seven color categories, which can indicate if someone has an infection, allergy or even whether they are breathing in too much polluted air.
'If your snot is changing color, you need to see what else is going on,' Dr Raj Sindwani, an ear, nose and throat specialist at the Cleveland Clinic said.
'It's the idea that you were doing fine, nothing was bothering you, and then something changed. You'll want to [think about] what else might have changed.'
Overall, experts said mucus should be clear in color — indicating everything is functioning normally.
But should this appearance vary or the mucus start to be produced in more copious amounts, this could indicate an underlying condition.
Mucus in the nose serves a vital function in keeping airways open by trapping dust and pathogens, helping someone to keep breathing normally.
It also boosts the immune system, with the mucus containing antibodies that can attack pathogens, and humidify air that is breathed in, preventing airways from drying out and becoming irritated.
Of the colors to be concerned about, doctors say that white, cream-colored or light yellow mucus suggests the body is fighting a cold or other viral infection, as the white is caused by the white blood cells fighting off infectious intruders.
When mucus turns denser and becomes yellowish-green, it means the body is fighting a bacterial infection or inflammation in the sinuses.
While reddish or pink snot may indicate that a small blood vessel in the nose burst at some point and the blood has now dried out.
Apart from this, brown colored mucus can also be sign of excessive exposure to air pollutants or heavy smoking while black mucus can indicate that the body is fighting a seriou fungal infection.
Researchers also say the amount of nasal mucus produced could also be a warning sign of a hidden complication.
If someone's nose produced a lot of mucus, this could be an indicator of a bacterial infection or allergic reaction to pollen - which could cause excessive mucus production by the nose.
In rare cases, experts say it may also be a very early warning sign of Parkinson's.
One the earliest signs Parkinson's patients have of the disease is a struggling to use the muscles in their nose and throat - causing saliva and mucus to accumulate in their nasal passage, according to the Parkinson's Foundation.
Analyzing a person's mucus may also offer insight into Alzheimer's disease.
Research has also shown that the presence of excessive amyloid proteins in the nasal mucus may indicate that a person is suffering from Alzheimer's disease.
Alzheimer's disease is believed to be caused by the development of amyloid plaques and tau tangles in the brain - which damage and kill cells.
Amyloid protein molecules stick together in brain cells, forming clumps called plaques. While tau proteins twist together in fiber-like strands called tangles.
The plaques and tangles block the ability of the brain's neurons to send electrical and chemical signals back and forth.
Over time, this disruption causes permanent damage in the brain that leads to Alzheimer's disease.
While it remains unclear how and when the quantity of amyloid proteins increases in the snot of people, studies have noted that the presence of the proteins can be found in nasal mucus is a clear biomarker for Alzheimer's disease in the brain.
As a result, scientists note that examining nasal fluid early on to detect the particular proteins can help slow down the progression of the disease by starting treatments early.
Additionally, new research indicates that examining the sticky fluid may also show whether a person is at risk of developing chronic obstructive pulmonary disease (COPD) – an inflammatory lung disease and the sixth leading cause of death in the US.
A July 2025 study published in the Journal of Allergy and Clinical Immunology found that long-time smokers who had high levels of a protein called IL-26 in their mucus were most likely to develop COPD.
The Swedish researchers found that high levels of the protein in the lungs and mucus of smokers was a clear sign of weak lung function and poor breathing capacity.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
24 minutes ago
- The Sun
I put funny turns & tinnitus down to worrying about my RAF son – but they were red flags for incurable cancer, says dad
A GRANDAD-of-two put his "funny turns" and tinnitus down to worrying about his son, who was in the RAF - but they turned out to be signs of incurable cancer. Chris Shade originally went to his doctor in 2017 as he was suffering from tinnitus and hearing a constant, high-pitched noise that 'drove him up the wall'. 10 10 He was also experiencing 'funny turns', could smell burning and was sometimes struggling to speak, but he put it down to his concern for his son, Craig, who was in Afghanistan with the RAF. However, his GP urgently referred the dad-of-two to Maidstone hospital for a brain scan to further investigate his symptoms. It was there that medics found a 'massive' grade two tumour on Chris' right frontal lobe. He was told he had a rare type of cancer known as oligodendroglioma, and that it was terminal. The 58-year-old said: 'Never in my life did I think I was going to have a brain tumour. I did not even have any headaches. 'I took the diagnosis on the chin and said, 'So what happens next?'. I thought, 'Bring it on, I am ready for the fight.' 'In some ways, I have to thank God for the tinnitus, as if I had not gone to the GP about my hearing, we would never have found it.' In March 2017, Chris underwent emergency surgery at King's College Hospital in London to remove the tumour, which was the first of many operations. His daughter Emma Welsh said: 'I cannot tell you what a worrying, distressing time this was. "By some miracle, the amazing doctors were able to remove it, and Dad was home before we knew it. Simple hand test that could reveal if you have a hidden brain tumour 'It was all such a shock, I do not think any of us had time to take it in.' However, two weeks later, Chris was admitted back into the hospital as a serious infection had set in, which led to two more brain surgeries to remove part of his skull replace the bone with a titanium plate. His wife of 40 years, Tina Shade, said: 'It was touch and go at that point. Every surgery, we did not know if he was going to make it.' Emma added: 'We nearly lost him. The stress and upset again are hard to describe, but we had to stay hopeful and strong for Dad.' 10 10 At the end of 2020, Chris, of Garner Drive, East Malling, was then given the 'devastating' news that another tumour had started to grow and underwent further surgery to remove it. Six months after the operation, the former instrument coordinator at Somerfield Hospital, in Maidstone, was told a third tumour had been found. His doctors decided not to put Chris through further surgery as it was growing slowly, and monitored his condition, telling him to go and make memories with his family. Instead, Chris underwent 10 months of treatment, including six weeks of radiotherapy and months of chemotherapy, to shrink the tumour, which finished earlier this year. He said: 'I have had some dark days, but I know there are people who are facing something worse than me. Although it does not make my pain any easier. 'The treatments are to extend my life; they cannot cure me. The doctors say it is like putting the tumours to sleep, and because it has worked, we know what to hit it with each time. 'I do not know how long I have. I could have one year, five years, or 15 years. I have had every scan and treatment they can offer me. Symptoms of oligodendroglioma OLIGODENDROGLIOMA is a type of brain tumour that develops from the brain's glial cells. It's a primary brain tumour, which means it starts in the brain as opposed to spreading there. Oligodendrogliomas are rare - about 3 out of every 100 primary brain tumours diagnosed in England between 1995 and 2017 were oligodendrogliomas, according to Cancer Research UK (CRUK). They're more common in adults, particularly in people aged 30-50, and are slightly more common in men than in women. Oligodendrogliomas may cause any of the symptoms common among brain tumours, particularly: Seizures Altered sensations, like strange smells or hallucinations relating to sense of smell Muscular weakness, particularly down one side of the body, and loss of control of bodily movements If the tumour is located in the frontal lobe, it can cause gradual changes in mood and personality, and weakness or numbness in the muscles of one side of the body. If it is located in the temporal lobe, this may cause problems with speech, coordination and memory. Source: The Brain Tumour Charity, CRUK 'I have the fight in me. There are a lot of people who might not get the time to fight it like I have, so I have to while I can. 'I hope my story gives people hope that there is a light at the end of the tunnel. You can fight this.' Tina added: 'I am really proud of him for what he has gone through and that he is still here. We have had dark days, but we always try to stay positive and laugh. 'It has been life-changing. Now, we are focusing on making memories and using the time we have been given.' 10 10 Lifelong dream During his battle, his family started a GoFundMe page to help raise money to pay for Chris to experience his lifelong dream of flying in a Spitfire at Biggin Hill. They raised more than £3,000. However, due to his surgeries they had to postpone the flight for several years. He also needed to lose five and a half stone gained during treatments to go up in the plane. However, last month, Chris, who has been helped by Brain Tumour Support and Tonbridge-based charity Babons Cancer Support, was able to fly in a WWII plane. The former part-time firefighter has now thanked everyone who donated. He said: 'It was an amazing day, I cannot express it. It was a bucket list experience. 'I am so grateful to all the people who donated and came along on the day. Everyone was so generous.' 10 10 10
The Independent
an hour ago
- The Independent
Major autism breakthrough could revolutionise treatments and care
Researchers have taken a 'transformative step' towards understanding the biology underlying autism after discovering four subtypes of the genetic condition. Scientists at Princeton University and the Simons Foundation analysed data from 5,000 children in SPARK, an autism cohort study, to group individuals based on their combination of traits. Instead of searching for genetic links to certain traits, researchers considered a range of over 230 traits in each individual, from social interactions to repetitive behaviours to developmental milestones. From this analysis, they were able to identify four subtypes of autism with different patterns of genetic variation. 'What we're seeing is not just one biological story of autism, but multiple distinct narratives," said Natalie Sauerwald, associate research scientist at the Flatiron Institute and co-lead author. 'This helps explain why past genetic studies often fell short—it was like trying to solve a jigsaw puzzle without realizing we were actually looking at multiple different puzzles mixed together. We couldn't see the full picture, the genetic patterns, until we first separated individuals into subtypes.' The four subtypes were Social and Behavioral Challenges, Mixed ASD with Developmental Delay, Moderate Challenges, and Broadly Affected. The first type relates to children reaching developmental milestones at a similar pace to children without autism, but they often experience co-occurring conditions like ADHD, anxiety or depression. The second type showed a delay in reaching developmental milestones but with no signs of co-occurring conditions. The third type, Moderate Challenges, shows core autism-related behaviours but less strongly than other groups, reaching milestones at a similar pace to children without autism and with no co-occurring conditions. The fourth type faces the most extreme and wide-ranging challenges. The first and third types were the most common, with 37 per cent and 34 per cent of participants found to be in each group, respectively, while the second and fourth types were the least common, with 19 per cent and 10 per cent of participants in each group. The findings highlight how genetic differences 'suggest distinct mechanisms behind superficially similar clinical presentations'. For example, children in both the Broadly Affected and Mixed ASD groups share some important traits, such as developmental delay and intellectual disability, but the former group showed the highest proportion of de novo mutations, which are not inherited from either parent, whereas the latter group was more likely to carry rare inherited genetic variants. The findings do not mean there are only four subtypes of autism; they establish the discovery of a data-driven framework showing there are at least four, and that they are meaningful both for clinical work and research at the genome level. For families navigating autism, knowing which subtype of autism their child has can offer new clarity, tailored care, support and community.
The Sun
an hour ago
- The Sun
The golden dose of Mounjaro that helps you shift the MOST weight – and why it's OK to still be hungry on the jab
EXPERTS have revealed the golden dose of Mounjaro that helps shift the most weight - and it's not the highest one. Weight loss jab users tend to start on lower doses and gradually increase them as their body adjusts, to a maximum of 15mg. 1 Many assume that anything under the maximum won't be "enough" to produce results. But analysis of patients taking the jab found that most - 86 per cent - lost significant amounts of weight at 10mg or lower. In fact, some of the best outcomes were seen at doses of 7.5mg, rather than the maximum 15mg. Patients on this dose - just 5mg above the starter amount of 2.5mg - had the highest average weight loss. Kiran Jones, clinical pharmacist at Oxford Online Pharmacy, said: 'This study reinforces that healthy, sustainable weight loss is possible without excessive pressure or maximal dosing." The analysis is based on anonymised data from 100 patients who were prescribed Mounjaro with Oxford Online Pharmacy. The data was collected in April 2025 and patients who were at various points in their treatment rather than all starting at the same time, as would happen for a study in a clinical setting. Researchers collected information such as patients' current dose, their starting body mass index (BMI) and the percentage of body weight lost. All the patients included in the audit got started on the recommended starting dose of 2.5mg. "Starting low helps the body adjust gradually to the medication and minimises early side effects," the report authors explained. I went on fat jabs but the hair loss was unbelievable so I quit - I'd rather be chubby with hair than skinny and bald Just over half - 51- of the patients were taking 5mg of Mounjaro at the time. Meanwhile, eight people were on 7.5mg, 27 people were on 10mg, one on 12.5mg and 13 on 15mg. Patients in the analysis lost up to 39kg. "Our audit showed that healthy, sustainable weight loss occurred at all Mounjaro dose levels," the report authors said. "There was a general trend of greater weight loss at higher doses, mirroring what has been found in clinical trials. "However, in our audit, the upward dose-dependent trend was not perfectly linear." This means that people on the highest doses didn't necessarily lose the most weight. The 7.5mg group had the highest average weight loss, followed by 15mg. What to do if you lose too much weight too quickly whilst on Mounjaro IF you're losing too much weight too quickly while on Mounjaro, it's important to take action to avoid potential health risks like muscle loss, malnutrition, dehydration, and fatigue. Here's what you can do: Evaluate Your Caloric Intake Mounjaro reduces appetite, which can make it easy to eat too little. If you're losing weight too fast (more than two to three lbs per week after the initial adjustment period), try: Tracking your food intake to ensure you're eating enough calories (apps like MyFitnessPal can help). Increasing protein intake to preserve muscle mass (aim for 0.6–1g per pound of body weight). Adding healthy fats and complex carbs (e.g., avocados, nuts, whole grains) for balanced energy. Adjust Your Dosage (With Doctor's Approval) If your weight loss is too rapid or causing side effects, your doctor may: Pause dose increases or lower your dosage. Adjust your treatment plan to stabilise your weight loss. Strength Training & Exercise To prevent muscle loss: Incorporate resistance training at least two to three times per week. Stay active with low-impact exercises like walking or yoga. Hydrate & Manage Electrolytes Drink enough water (Mounjaro can reduce thirst). Electrolytes matter - Consider adding magnesium, sodium, and potassium if you feel weak or fatigued. Monitor for Malnutrition & Deficiencies Rapid weight loss can cause vitamin/mineral deficiencies (especially B12, iron, and electrolytes). If you experience: Fatigue, hair loss, or dizziness, ask your doctor about supplements. Consider Further Medical Guidance If your weight loss is excessive or causing health concerns, speak with your healthcare provider. They might adjust your dosage, diet, or exercise plan to help stabilise your weight loss. "At first glance, this might suggest that 7.5mg is more effective than the highest dose," researchers explained. "However, while some patients on 7.5mg achieved greater weight loss than those on higher doses, others lost far less. "This variability highlights the highly individual response to Mounjaro. Outcomes are shaped not just by dose, but by lifestyle, health status, adherence, and other personal factors." Researchers noted that that smaller group sizes for some dosage amounts - just eight patients on 7.5mg and 13 on 15mg - make the results sensitive to outliers. This means that if someone lost much more weight than others in the same group, this could be skewing the averages worked out by the report authors. "A larger dataset would help smooth these fluctuations and better reflect true trends," they said. "Still, the fact that peak average weight loss occurred at a lower dose is meaningful. "It reinforces that the maximum dose isn't required to see meaningful results." The BMI patients started at did seem to influence weight loss results. Those with a BMI over 40 when they started taking the jabs were more likely to shed over 20 per cent of their body weight. "Patients with higher BMIs who achieved greater weight loss were more likely to be on higher doses of 10mg or more, but this was not always the case," the researchers said. "Some patients achieved significant results at moderate doses like 5mg or 7.5mg, reinforcing that dose alone doesn't determine success and that response to Mounjaro is highly individual." The study authors noted that they couldn't draw conclusions about how quickly patients were able to shed pounds on Mounjaro, as they didn't collect data on overall treatment duration, starting date, or how quickly people upped their dose. They also advised caution in interpreting the results, especially for the higher dose groups that had fewer people in them. Is it normal to be hungry on the jabs? A common misconception among jab users is that they shouldn't feel any hunger at all while taking them. This can lead to unnecessary concerns about whether their current dose is working, especially when they're taking lower doses. One of the ways GLP-1 medications like Mounjaro work is by calming hunger signals in the brain, helping patients feel satisfied with smaller portions. But they do not and should not eliminate hunger altogether. "Hunger is the body's way of signalling it needs fuel, and even patients on higher doses like 12.5mg or 15mg should feel hunger at times," the report authors noted. Kiran added: 'People think these medicines switch off hunger completely, but that's not how they work. "Being able to eat is normal. Success looks different for everyone, and often, the biggest wins are quiet ones: more energy, less breathlessness, and better sleep. 'Becoming healthier without extreme diets or private clinics is a powerful example of what good, regulated care can achieve. Patients need safety, not pressure.' Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
